Private Equity
Johnson & Johnson has agreed to buy Alios BioPharma for about $1.75 billion in cash.
1 min read · 01 October 2014
Amplify, Intel, Emergence and other venture firms change up their rosters
6 min read · 01 October 2014
2 min read · 01 October 2014
Triple-sizing DN’s new fund; Chiesi’s rare-disease pool; kick-starting Spain’s VC market
3 min read · 01 October 2014
Paris life science investor eyes Scandinavia; UK fund seeks finance specialists; Permira exec quits Russia fund
4 min read · 01 October 2014
Helsinki firm Inventure, which has a panache for hardware, is raising a $98 million sophomore fund
3 min read · 01 October 2014
The index of VC-backed stocks rises more than 43.5 points to end August at highest point since March
1 min read · 01 October 2014
Venture activity down across the board in August, but total IPO proceeds from VC-backed companies perks up after Mobileye debut
2 min read · 01 October 2014
DCM looks to growth-fund strategy; TrueBridge closes FoF; Oak HC/FT wraps up debut fund; and other venture-related fundraising updates
6 min read · 01 October 2014
VCs advise to take a few weeks to get to know your entrepreneur; Draper loses bid for Six Californias
3 min read · 01 October 2014
